Seems a very solid result. They are making NPAT of roughly 75 cents per half year (150 cents per year) in a way that looks sustainable. When combined with their cash holdings and balance sheet strength and conservative financial management it's easy to justify the current share price and a substantial jump in the share price wouldn't stretch their valuation in my view.
- Forums
- ASX - By Stock
- LYL
- Ann: 1HFY2024 Investor Presentation
Ann: 1HFY2024 Investor Presentation, page-2
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LYL (ASX) to my watchlist
|
|||||
Last
$13.00 |
Change
0.120(0.93%) |
Mkt cap ! $516.6M |
Open | High | Low | Value | Volume |
$12.90 | $13.20 | $12.90 | $1.581M | 121.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 664 | $12.98 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.10 | 202 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 664 | 12.980 |
1 | 202 | 12.960 |
2 | 1500 | 12.950 |
1 | 202 | 12.940 |
1 | 350 | 12.900 |
Price($) | Vol. | No. |
---|---|---|
13.100 | 202 | 1 |
13.120 | 202 | 1 |
13.140 | 202 | 1 |
13.160 | 202 | 1 |
13.180 | 758 | 1 |
Last trade - 16.10pm 03/07/2024 (20 minute delay) ? |
Featured News
LYL (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online